NDTV-Dettol Banega Swasth Swachh India NDTV-Dettol Banega Swasth Swachh India
  • Home/
  • News/
  • Government Places Purchase Order With Serum Institute For 1.1 Crore Doses Of Oxford COVID-19 Vaccine


Government Places Purchase Order With Serum Institute For 1.1 Crore Doses Of Oxford COVID-19 Vaccine

The Covishield vaccine doses would be initially shipped to 60 consignment points from where those would be distributed further, the sources said

Government Places Purchase Order With Serum Institute For 11 Million Doses Of Oxford COVID-19 Vaccine
  • Centre plans to cover 30 crore people in the first part of vaccine drive
  • PM has called this vaccination drive as the world's largest
  • Covishield has been developed by Oxford University and AstraZenaca

New Delhi: The government on Monday (January 11) placed a purchase order with Serum Institute of India for 1.1 crore doses of Oxford COVID-19 vaccine, Covishield, each costing Rs.210, including the GST, and committed to buy 4.5 crore more by April, together amounting to over Rs 1,100 crore, sources said. Dispatch of the vaccine is likely to start by early Tuesday morning, they said. According to the order placed, each dose of the vaccine has been priced at Rs.200 and with GST of Rs.10, it would cost Rs.210.

Also Read: Centre To Bear Expenses For First Round Of Vaccination, Jabs For 30 Crore In First Few Months: PM Modi

The HLL Lifecare Limited, a public sector undertaking, issued the supply order on behalf of the Union Health Ministry. The first order of 1.1 crore doses will be worth Rs.231 crore, while the total amount, including the commitment for 4.5 crore doses, with the total estimated to reach Rs.1,176 crore at current rates, sources said.

It is further informed that there is a commitment to purchase further 450 lakh doses from Serum Institute of India Pvt Limited, a manufacturer (through subsidiary Serum Institute of Life Sciences Pvt Limited) at Rs 200 per dose plus GST if applicable by April 2021, the letter of comfort signed by Prakash Kumar Singh, Additional Director, Government and Regulatory Affairs at Serum Institute of India (SII) and R S Manku, Vice President (Govt Business) stated.

Also Read: As India Gears Up To Kick-starts COVID-19 Vaccination Drive From January 16, Dr Randeep Guleria Explains When Will The Common Man Get The Vaccine

“This is in continuation to the supply order dated January 11 for supply of 1.1 crore doses of Covishield vaccine as approved by DCGI vide permission dated January 3 for restricted use in emergency situation,” it stated.

The Union health ministry is also likely to soon sign a purchase order for another anti-coronavirus vaccine, Covaxin, which has been indigenously developed by Bharat Biotech, a source said. The Covishield vaccine doses would be initially shipped to 60 consignee points across India from where those would be distributed to various vaccination centres, the sources said. Vaccine-laden trucks will move out from Manjari location of the Pune-based SII amid elaborate police security. The Maharashtra government has decided to provide police security to the trucks carrying the vaccine up to airports and to the borders of the state. As many as 2,54,500 doses of Covishield are set to be delivered at Delhi’s central storage, Rajiv Gandhi Super Speciality Hospital, in Tahirpur.

Also Read: Pune Firm Gears Up To Transport COVID-19 Vaccine Vials From Serum Institute Of India

India had recently approved two vaccines, Oxford’s Covishield manufactured by SII in the country and Bharat Biotech’s Covaxin, for restricted emergency use. According to the health ministry, two doses of the vaccine need to be taken by an individual 28 days apart to complete the immunisation schedule. Protective levels of antibodies are generally developed two weeks after receiving the second dose, it has said.

The country will launch its COVID-19 vaccination drive from January 16 in what Prime Minister Narendra Modi has called the world’s largest inoculation programme with priority to be given to nearly three crore healthcare and frontline workers. According to the ‘COVID-19 Vaccine Operational Guidelines”, the shots will be offered first to an estimated one crore healthcare workers, and around two crore frontline workers, and then to persons above 50 years of age, followed by persons younger than 50 years of age with associated comorbidities based on evolving pandemic situation.

Also Read: Co-WIN Shall Form Foundation Of COVID-19 Inoculation Drive: Centre

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the current COVID-19 pandemic, the need for WASH (WaterSanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fight malnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues like air pollutionwaste managementplastic banmanual scavenging and sanitation workers and menstrual hygiene

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This website follows the DNPA Code of Ethics

© Copyright NDTV Convergence Limited 2024. All rights reserved.